HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000

Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000

Frequency of the DYT1 Mutation in Primary Torsion Dystonia Without Family History
ArchNeurol 57:333-335, Brassat,D.,et al, 2000

Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000

Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000

Physical Activity and Risk of Stroke in Women
JAMA 283:2961-2967, Hu,F.B.,et al, 2000

Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000

North Carolina Stroke Prevention and Treatment Facilities Survey
Stroke 31:66-70, Goldstein,L.B.,et al, 2000

Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000

The DYT1 Phenotype and Guidelines for Diagnostic Testing
Neurol 54:1746-1753,1718, Bressman,S.B.,et al, 2000

Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000

Secondary Prevention of Transient Ischaemic Attack and Stroke
BMJ 320:991-994, Lees,K.R.,et al, 2000

Results of Radiosurgery for Brain Stem Arteriovenous Malformations
JNNP 68:563-570,548, Kurita,H.,et al, 2000

Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000

Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000

The Protective Effect of Moderate Alcohol Consumption on Ischemic Stroke
JAMA 281:53-60,104, Sacco,R.L.,et al, 1999

Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999

Exercise and Risk of Stroke in Male Physicians
Stroke 30:1-6, Lee,I-M.,et al, 1999

Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly
Arch Int Med 159:38-44, Bots,M.L.,et al, 1999

Risk Factor Modification in Stroke Prevention,The Experience of a Stroke Clinic
Stroke 30:16-20, Joseph,L.N.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Oral Anticoagulation in Patients with Atrial Fibrillation:Adherence with Guidelines in an Elderly Cohort
Am J Med 106:165-171, White,R.H.,et al, 1999

Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999

Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999

Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999

Paraneoplastic Syndromes
Arch Neurol 56:405-408, Dalmau,J.O.&Posner,J.B., 1999

Clinicopath Conf:Burkitt-Like B-Cell Lymphoma, Nocardiosis
NEJM 340:1188-1196, Case 11-1999, 1999

Infantile Neuroaxonal Dystrophy,Clinical Spectrum and Diagnostic Criteria
Neurol 52:1472-1478, Nardocci,N.,et al, 1999

Factors Associated with Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation, Analysis of 2012 Participants in the SPAF-I-III Clinical Trials
Stroke 30:1223-1229, Hart,R.G.,et al, 1999

Risk Assessment and Anticoagulation for Primary Stroke Prevention in Atrial Fibrillation
Stroke 30:1218-1222, Kalra,L.,et al, 1999

Familial Paroxysmal Dystonic Choreoathetosis,Clinical Findings in a Large Japanese Family and Genetic Linkage to 2q
Arch Neurol 56:721-726, Matsuo,H.,et al, 1999

Is Carotid Endarterectomy Appropriate for Asymptomatic Stenosis?
Arch Neurol 56:877-881, Castaldo.J.E., 1999

Is Carotid Endarterectomy Appropriate for Asymptomatic Stenosis?
Arch Neurol 56:879-881, Chaturvedi,S., 1999

A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke
Arch Int Med 159:1248-1253, Johnson,E.S.,et al, 1999

Low-Dose and High-Dose Acetylsalicylic Acid for Patients Undergoing Carotid Endarterectomy:A Randomised Controlled Trial
Lancet 353:2179-2184,2172, Taylor,D.W.,et al, 1999

Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States
Ann Int Med 130:963-970, Ascherio,A.,et al, 1999

Physical Activity and Ischemic Stroke Risk, The Atherosclerosis Risk in Communities Study
Stroke 30:1333-1339, Evenson,K.R.,et al, 1999

Effects of Leisure-Time Physical Activity and Ventilatory Function on Risk for Stroke in Men:The Reykjavik Study
Ann Int Med 130:987-990, Agnarsson,U.,et al, 1999

Therapeutic Benefit, Aspirin Revisited in Light of the Introduction of Clopidogrel
Stroke 30:1716-1721, Gorelick,P.B.,et al, 1999

Ptosis, Blepharospasm, and Apraxia of Eyelid Opening Secondary to Putaminal Hemorrhage
Neurol 53:652, Verghese,J.,et al, 1999

A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation, A Randomized Controlled Trial
JAMA 282:737-743,779, Man-Son-Hing,M.,et al, 1999

Homocyst(e)ine and Risk of Cerebral Infarcdtion in a Biracial Population, The Stroke Prevention in Young Women Study
Stroke 30:1554-1560, Kittner,S.J.,et al, 1999

Rapid-Onset Dystonia-Parkinsonism:Linkage to Chromosome 19q13
Ann Neurol 46:176-182, Kramer,P.L.,et al, 1999

The North American Symptomatic Carotid Endarterectomy Trial, Surgical Results in 1415 Patients
Stroke 30:1751-1758,1745, Ferguson,G.G.,et al, 1999

Prospective Study of Aspirin Use and Risk of Stroke in Women
Stroke 30:1764-1771, Iso,H.,et al, 1999

Globus Pallidus Deep Brain Stimulation for Generalized Dystonia:Clinical and PET Investigation
Neurol 53:871-874, Kumar,R.,et al, 1999

Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol 56:1087-1092, Wilterdink,J.L.&Easton,J.D., 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999

Clinical and MRI Findings in Spinocerebellar Ataxia Type 5
Neurol 53:1355-1357, Stevanin,G.,et al, 1999